Women want a low-dose birth control option
In an online survey of 1000 women considering hormonal birth control1

The survey conducted by Bayer in September 2019 included women aged 18-44 who were currently taking or considering taking hormonal prescription birth control in the next 12 months.1
IUD=intrauterine device.
Kyleena acts locally and provides low hormone levels
Comparison of simulated typical serum LNG concentrations2*

Low daily release rates3

LNG=levonorgestrel.
High contraceptive efficacy maintained over 5 years3
Kyleena is the lowest-dose 5-year IUD3

The efficacy of Kyleena over 5 years was studied in parous and nulliparous women across a broad range of ages and body mass index (BMI).3
- Ages in the clinical trial subjects ranged from 18 to 35
- The weight range for Kyleena-treated women was 38 kg to 173 kg (84 lbs to 381 lbs)
- Mean BMI was 25.3 kg/m2 (range 15.2-57.6 kg/m2)
Year 1: Pearl Index of 0.16; 95% upper CL of 0.58; cumulative 5-year pregnancy rate, based on 13 pregnancies, estimated by the Kaplan-Meier method was 1.45%; 95% upper CL of 2.53%.3
CL=confidence limit.
Request a Rep
Stay up to date with clinical information and virtual trainings for Kyleena.
See how Kyleena impacts bleeding
Know what patients may expect in the first 3 to 6 months and up to 5 years of use.
A non-daily contraception option
Learn more about Kyleena as a non-daily contraception option.